2020
DOI: 10.1093/heapol/czaa050
|View full text |Cite
|
Sign up to set email alerts
|

Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study

Abstract: Abstract The Syrian conflict has caused enormous displacement of a population with a high non-communicable disease (NCD) burden into surrounding countries, overwhelming health systems’ NCD care capacity. Médecins sans Frontières (MSF) developed a primary-level NCD programme, serving Syrian refugees and the host population in Irbid, Jordan, to assist the response. Cost data, which are currently lacking, may support programme adaptation and system scale up of such … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
17
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 29 publications
(37 reference statements)
1
17
0
Order By: Relevance
“…From the patient perspective, the mean SBP in hypertensive patients decreased by 6.6 mmHg within the first 6 months, from mean 137.9 mmHg (95% CI 137.1 to 138.7) at entry/new diagnosis to 131.3 mmHg (95% CI 130.3 to 132.3) Similarly, there was a marked improvement in FBG level by 1.43 mmol/l from a mean of 10.40 mmol/l (95% CI 10.19 to 10.62) at entry/new diagnosis to 8.97 mmol/l (95% CI 8.67 to 9.26) by 6 months; most of this improvement occurred within the first 3 months. These results and those related to treatment interruption are elaborated on in our companion paper [ 38 ].…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…From the patient perspective, the mean SBP in hypertensive patients decreased by 6.6 mmHg within the first 6 months, from mean 137.9 mmHg (95% CI 137.1 to 138.7) at entry/new diagnosis to 131.3 mmHg (95% CI 130.3 to 132.3) Similarly, there was a marked improvement in FBG level by 1.43 mmol/l from a mean of 10.40 mmol/l (95% CI 10.19 to 10.62) at entry/new diagnosis to 8.97 mmol/l (95% CI 8.67 to 9.26) by 6 months; most of this improvement occurred within the first 3 months. These results and those related to treatment interruption are elaborated on in our companion paper [ 38 ].…”
Section: Resultsmentioning
confidence: 99%
“…We explored trends in intermediate clinical outcomes and treatment interruption from programme and patient perspectives, and the factors associated with these trends. We included patients 18 years and older with hypertension and/or diabetes type II (DM II), exploring control of systolic blood pressure (SBP < 140 mmHg) and glycaemia [fasting capillary blood glucose (FBG) ≤ 180 mg/dL or HbA1c < 8%] [21]. We plotted monthly means for each outcome (SBP, FBG, HbA1c or treatment delay) and the proportion of monthly visits at which targets were achieved.…”
Section: Retrospective Cohort Studymentioning
confidence: 99%
See 3 more Smart Citations